在上皮卵巢癌中基于DNA甲基化的预后亚型和签名的识别

Jingjing Zhou1, Yuxin Chen1, Wei Liu1

  • 1Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Molecular Cancer Epidemiology of Tianjin, Tianjin, China, Tianjin Medical University Cancer Institute and Hospital, Huanhu Xi Road, TiyuanBei, Hexi District, Tianjin, 300060, P.R. China.

Human genetics
|December 27, 2025
PubMed
概括

这项研究确定了四种上卵巢癌 (EOC) 的DNA甲基化亚型,揭示了不同的预后和治疗反应. 这些发现为个性化EOC治疗策略提供了新的途径.